Unknown

Dataset Information

0

Development and immunochemical evaluation of a novel chicken IgY antibody specific for KLK6.


ABSTRACT: UNLABELLED: BACKGROUND:Human kallikrein-related peptidase 6 (KLK6) has been implicated in various types of cancer and in neurodegenerative and demyelinating diseases including multiple sclerosis. Further, anti-KLK6 antibodies attenuated disease manifestations in the mouse model of multiple sclerosis. Availability of specific antibodies against KLK6 is fundamental to the development of improved diagnostic and/or immunotherapeutic applications. Here, we exploited the enhanced immunogenicity of mammalian proteins in avian species to generate a polyclonal antibody against KLK6. RESULTS:Chicken were immunized with recombinant KLK6 and antibodies Y (IgYs) were purified from egg yolk with a simple procedure and evaluated for KLK6 detection by ELISA and Western blot using recombinant proteins and human cell lysates and supernatants. The anti-KLK6 Y polyclonal exhibited high affinity for KLK6 with a detection limit of 30 fmol. On the other hand, the widely used rabbit polyclonal antibody that was raised against the same recombinant KLK6 had a detection limit of 300 fmol. Moreover, the IgYs did not display any crossreactivity with recombinant KLKs or endogenous KLKs and other cellular proteins. CONCLUSIONS:Based on its high specificity and sensitivity the developed anti-KLK6 IgY is expected to aid the development of improved diagnostic tools for the detection of KLK6 in biological and clinical samples.

SUBMITTER: Sotiropoulou G 

PROVIDER: S-EPMC3554440 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Development and immunochemical evaluation of a novel chicken IgY antibody specific for KLK6.

Sotiropoulou Georgia G   Pampalakis Georgios G   Prosnikli Evangelia E   Evangelatos Gregory P GP   Livaniou Evangelia E  

Chemistry Central journal 20121205 1


<h4>Unlabelled</h4><h4>Background</h4>Human kallikrein-related peptidase 6 (KLK6) has been implicated in various types of cancer and in neurodegenerative and demyelinating diseases including multiple sclerosis. Further, anti-KLK6 antibodies attenuated disease manifestations in the mouse model of multiple sclerosis. Availability of specific antibodies against KLK6 is fundamental to the development of improved diagnostic and/or immunotherapeutic applications. Here, we exploited the enhanced immuno  ...[more]

Similar Datasets

| S-EPMC2782010 | biostudies-literature
| S-EPMC8778912 | biostudies-literature
| S-EPMC5889419 | biostudies-literature
| S-EPMC5527699 | biostudies-other
| S-EPMC8076637 | biostudies-literature
| S-EPMC8117566 | biostudies-literature
| S-EPMC9815496 | biostudies-literature
| S-EPMC6466411 | biostudies-literature
| S-EPMC4802925 | biostudies-literature
| S-EPMC7568776 | biostudies-literature